A 2018 Office for Economic Cooperation and Development survey found that consumer spending on pharmaceuticals, including over-the-counter drugs was $1,229 per capita in the United States, more than a third higher than the next countries in this OECD survey: Switzerland, Germany, Canada, and Japan (Young, 2020). The creation of a Virginia Prescription Drug Affordability Board could play a significant role in reducing consumer costs for certain prescription medications, as well as affecting the profit margins of the companies that produce and sell them in the state of Virginia